-
DERA Class for Managing Resistant Hypertension
18 Jun 2025 18:53 GMT
… class for resistant hypertension treatment.
Having an entirely new antihypertensive drug class is … who have tried most available medications without success due to … the therapeutic arsenal for treating resistant hypertension cases that previously had …
-
Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable
18 Jun 2025 16:04 GMT
… -cost oral medications from Cost Plus Drugs as a way to treat obesity … as diabetes, high cholesterol, and hypertension.1
As part of the … to impress your pharmacy colleagues with the latest drug information, industry trends …
-
Smart Thrombosis Care: The Rise of Closed-Loop Diagnosis-to-Treatment Nano Systems
18 Jun 2025 15:54 GMT
… developed a noninvasive theranostic platform integrating sonodynamic and mechanical thrombolysis for treating … antithrombotic medications: … portal hypertension: … treatment protocol: identifying comprehensive safety signals using FDA database. Front Pharmacol …
-
FDA adds Gradient denervation tech to advisory program
18 Jun 2025 13:19 GMT
… from the FDA, patients, providers and payers. It facilitates rapid development and … Gradient. “There are no approved drug or device therapies in the … underserved patients.”
Renal denervation for treating hypertension continues to pick up steam …
-
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
18 Jun 2025 11:17 GMT
… and Drug Administration (FDA) for the development of its novel technology intended to treat … for the treatment of pulmonary hypertension. Gradient leverages intellectual property developed at Stanford …
-
Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire
18 Jun 2025 11:17 GMT
… de la Food and Drug Administration (FDA, Agence des produits alimentaires … , CDRH) de la FDA a lancé le programme … notre collaboration avec la FDA, depuis le lancement de … l’hypertension pulmonaire. Gradient exploite la propriété intellectuelle développée à …
-
Losartan Potassium Active Pharmaceutical Ingredient API Market Report 2025 – Growth & Competitive Advantage
18 Jun 2025 09:35 GMT
… processes, development of advanced drug delivery … hypertension underlines the need for effective treatment … Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4 By Application: Hypertension … report/medication-adherence-global- …
-
Blind Spots: Comparing the Vision Costs of Weight-Loss Drugs
18 Jun 2025 10:22 GMT
… had taken semaglutide and developed severe optic neuropathy. One … -angle glaucoma and ocular hypertension was significantly lower in … taking other weight-loss medications, such as the combination … Drug, New Insights
Approved by the FDA in 1959 for the treatment …
-
Kidney Fibrosis Treatment Market Analysis 2025 – Insights For Long-Term Investment & Planning
18 Jun 2025 09:15 GMT
… research and development investments in … treatment, and a mounting incidence of diabetes and hypertension … trial activity will further augment the growth of the kidney fibrosis treatment … International GmbH, Vertex Pharmaceuticals Incorporated, Chinook …
-
MIT’s Once-a-Week Pill Could Revolutionize Schizophrenia Treatment
18 Jun 2025 03:13 GMT
… illnesses like hypertension and asthma, taking medication every … developed a pill that can be taken once a week, gradually releasing medication … the weekly treatment maintained steady drug levels in … , senior director of pharmacometrics at Certara, are …